FDA Preemption Policy Gets First Appeals Court Test With Zoloft, Paxil Cases
Executive Summary
A federal appellate court will take up the issue of whether FDA approved labeling preempts state litigation claiming companies failed to warn of a product's risks, following years of conflicting rulings from district courts
You may also be interested in...
FDA Preemption Cases Expected To Stay On Top Of Legal Calendar In 2008
As 2007 came to an end, lawyers, judges and others involved in pharmaceutical litigation had just one word on their minds: preemption
FDA Preemption Cases Expected To Stay On Top Of Legal Calendar In 2008
As 2007 came to an end, lawyers, judges and others involved in pharmaceutical litigation had just one word on their minds: preemption
Pharma Companies Swat Down Novel Theories Of Product Liability
For the last five years, brand name companies have been pulled into court to battle claims that they are liable for injuries caused by a generic version of their drug